Beech Tree Labs (BTL)
focuses on the discovery and early-stage development of pharmaceutical and nutraceutical formulations that address chronic disorders. Characteristic of a streamlined approach, BTL then out-licenses product candidates in order to finalize clinical development or go straight to market, depending on the specific candidate. The Company employs proven, rapid, and inexpensive methods to capitalize on an extensive and ever-growing portfolio of patents covering many potential products.The unique characteristics of these agents include:
- comprised of naturally-occurring molecules;
- low-dosage efficacy;
- placebo-level, if any, adverse effects.
BTL is an innovative company with attributes that clearly distinguish its prospects for long-term success from most other biotech start-ups. Specifically, it has:
- an established base of patented product candidates, several ready for formal clinical evaluation;
- a low burn rate and a proven cost and time effective product development strategy;
- products with inherently low risk of side effects and high profit margin potential;
- no capital-intensive manufacturing process.
Resulting from the experience of its management team, Beech Tree Labs has several product candidates in various stages of development, and a robust pipeline of both pharmaceutical and nutraceutical candidate products.